Dr. Jadee Neff Elected to Association of Molecular Pathology Program Directors’ Committee

In November 2024, Assistant Professor of Hematopathology and Molecular Genetic Pathology Jadee Neff, MD, PhD, was elected to the Molecular Genetic Pathology (MGP) Program Directors’ Council for the MGP Fellowship Program Directors’ Committee within the Association of Molecular Pathology (AMP).  The term spans three years: this year Neff is the chair-elect; next year she will be the chair; and in the final year she will transition to a past-chair position.

The Program Director’s Council has standardized the MGP fellowship recruitment process via a unified timeline, and most recently, via the National Resident Matching Program (NRMP) Match. As part of her charge, Neff plans to design a mechanism to assess the recruitment process continuously and adjust it based on year-to-year recruitment success feedback from programs.

The Council also curates the MGP fellowship in-service exam (FISE) question bank, reviewing each question for quality, relevance, and redundancy. The test is administered biannually, and Neff intends to create a feedback system to evaluate and consistently enhance the quality and relevance of the FISE for the MGP board exam. She also hopes to increase MGP fellowship visibility to pathology residents via dedicated fellowship fairs and other marketing opportunities.

Neff is the associate medical director of the Molecular Pathology, Genetics and Genomics Clinical Laboratory; associate director of Genomics in the BioRepository & Precision Pathology Center (BRPC); program director of the Molecular Genetic Pathology Fellowship; and a molecular pathologist and Molecular Tumor Board specialist in the National Precision Oncology Program (NPOP) within the Veterans’ Health Administration (VHA) Specialty Care Services.

As a diagnostic hematopathologist and molecular genetic pathologist, her clinical duties focus on the histologic examination of tissue and bone marrow biopsies to diagnose hematologic malignancies (leukemia, lymphoma, myeloma, etc.). She also examines DNA from tumors or blood to detect inherited or acquired mutations that can guide therapeutic management and predict clinical outcomes.

Her research interests include the following:

1. Spatial transcriptomic and proteomic profiling in human malignancies, with particular focus on the tumor microenvironment and immune milieu
2. Genetic biomarker discovery in hematologic and solid tumor malignancies
3. Development of workflow and algorithmic processes that maximize test utilization efficiency and quality health care
4. Providing diagnostic clarity through exploration of challenging diagnostic dilemmas and missed diagnoses